House · Passed · 2025-2026 Regular Session
HB 473: Controlled substances; Schedule I; provide certain provisions
Last action May 1, 2025 · Effective Date
House Bill 473 updates Georgia's list of controlled substances and dangerous drugs, adding newly identified synthetic drugs to Schedule I and adding many recently approved prescription medications to the state's dangerous drugs list.
The summaries below were written by an AI model (claude-sonnet-5) from the text of the bill and are not part of it. Quote the text, not the summary. The stored text is the Enrolled version, the latest the General Assembly's website lists.
In plain language
Georgia law keeps a running list of controlled substances (drugs regulated because of abuse potential) and a separate list of dangerous drugs (medications that legally require a prescription). Both lists need periodic updates as new substances appear on the illegal drug market or new medicines get approved. This bill amends Georgia's controlled substances law (O.C.G.A. § 16-13-25) to correct a chemical name, reclassify one substance from a placeholder listing to a named substance, and add two new synthetic substances, including a chemical group linked to synthetic drugs. It also amends the dangerous drug law (O.C.G.A. § 16-13-71) by adding roughly 60 newly named prescription drugs and biologics, plus one allergen powder product, to the list of medications requiring a prescription. The bill does not change penalties or enforcement procedures; it only updates the substances covered by existing rules. It would take effect immediately once signed by the Governor, or automatically become law without a signature.
What the bill does
- Corrects the chemical name of a Schedule I substance from a general 'methyl' compound to the specific compound '2-methyl-AP-237.'
- Replaces a placeholder ('Reserved') Schedule I listing with the named substance Acetylpsilocin, a hallucinogenic compound.
- Adds Ethylphenidate and a tetrahydrothiophene chemical group as newly regulated Schedule I controlled substances.
- Adds roughly 60 newly named prescription drugs, biologics, and vaccines (such as Resmetirom, Ensifentrine, and a smallpox/mpox vaccine) to Georgia's dangerous drug list.
- Adds a peanut allergen powder product to the dangerous drug list, meaning it would require a prescription under Georgia law.
Who it affects
Pharmacists, physicians, and drug manufacturers who must classify and dispense the newly listed medications correctly; law enforcement and prosecutors handling cases involving the newly named Schedule I substances; and patients who rely on the newly listed prescription drugs and vaccines.
Why it matters
Keeping these lists current means new synthetic drugs can be prosecuted as controlled substances and new medications are properly classified as requiring a prescription, affecting how pharmacies dispense them and how law enforcement handles emerging street drugs.
Key provisions
- Section 1 corrects a Schedule I chemical name in O.C.G.A. § 16-13-25 from 'Methyl' to '2-methyl-AP-237.'
- Section 2 replaces a 'Reserved' placeholder with the named substance Acetylpsilocin under Schedule I.
- Section 3 adds Ethylphenidate as a new Schedule I substance.
- Section 4 adds the tetrahydrothiophene group to the chemical classes covered under Schedule I.
- Section 5 adds about 60 newly approved prescription drugs and biologic products to the dangerous drug list in O.C.G.A. § 16-13-71.
- Section 6 adds a peanut allergen powder product to the dangerous drug list.
- Section 7 makes the Act effective immediately upon the Governor's signature or upon becoming law without signature.
From the bill
“(CC) Acetylpsilocin (4-acetoxy-N,N-dimethyltryptamine, 4-AcO-DMT);”
“(III) Tetrahydrothiophene group;”
Status timeline
- Effective Date
- Act 45
- House Date Signed by Governor (House)
- House Sent to Governor (House)
- Senate Passed/Adopted (Senate)
- Senate Third Read (Senate)
- Senate Read Second Time (Senate)
- Senate Committee Favorably Reported (Senate)
Show full history (15 actions)
- Senate Read and Referred (Senate)
- House Passed/Adopted (House)
- House Third Readers (House)
- House Committee Favorably Reported (House)
- House Second Readers (House)
- House First Readers (House)
- House Hopper (House)
Sponsors
- Ron Stephens (R, HD-164)
- Lee Hawkins (R, HD-27)
- Mark Newton (R, HD-127)
- Ben Watson (R, SD-1)
Votes
- House voteMarch 3, 2025
170 yea, 0 nay (4 not voting, 6 excused)
- Senate voteMarch 27, 2025
53 yea, 0 nay (1 not voting, 2 excused)
Topics
- controlled substances
- drug scheduling
- prescription drug regulation
- Georgia drug law